← Back to all signals
RESEARCH PAPER ANALYSIS

Racial and Ethnic Variation in Survival in Early-Onset Colorectal Cancer.

AI interpretation is pending for this paper.

Open original publication →
PMID39576642
JournalJAMA network open
Publication Date2024-11-04
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

IMPORTANCE: Rates of early-onset (before 50 years of age) colorectal cancer (EOCRC) are increasing, with notable differences across racial and ethnic groups. Limited data are available on EOCRC-related mortality differences when disaggregating racial and ethnic groups. OBJECTIVE: To investigate racial and ethnic differences in EOCRC mortality, including disaggregation of Asian American populations separately, including Native Hawaiian or Other Pacific Islander populations and specific Asian American groups, and to quantify the contribution of clinical and sociodemographic factors accounting for these differences. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included California Cancer Registry data for individuals aged 18 to 49 years with EOCRC between January 1, 2000, to December 31, 2019. Median follow-up was 4.2 (IQR, 1.6-10.0) years. The data analysis was conducted between July 1, 2021, and September 30, 2024. EXPOSURE: Race and ethnicity defined as Asian American (and 7 disaggregated subgroups), Hispanic, Native Hawaiian or Other Pacific Islander, non-Hispanic American Indian or Alaska Native, non-Hispanic Black, and non-Hispanic White. MAIN OUTCOMES AND MEASURES: Cox proportional hazards regression models were used to measure association between race and ethnicity and CRC mortality risk, yielding adjusted hazard ratios (AHRs) and 95% CIs. Associations of sociodemographic, health system, and clinical factors with differences in mortality by racial and ethnic minority group were assessed using sequential modeling. RESULTS: There were 22 834 individuals diagnosed with EOCRC between 2000 and 2019 (12 215 [53.5%] male; median age, 44 [IQR, 39-47] years). Racial and ethnic identity included 3544 (15.5%) Asian American, 6889 (30.2%) Hispanic, 135 (0.6%) Native Hawaiian or Other Pacific Islander, 125 (0.5%) non-Hispanic American Indian or Alaska Native, 1668 (7.3%) non-Hispanic Black, and 10 473 (45.9%) non-Hispanic White individuals. Compared with non-Hispanic White individuals, higher EOCRC mortality was found for Native Hawaiian or Other Pacific Islander (AHR, 1.34; 95% CI, 1.01-1.76) and non-Hispanic Black (AHR, 1.18; 95% CI, 1.07-1.29) individuals. Disaggregation of Asian American ethnic groups revealed notable heterogeneity, but no single group had increased EOCRC mortality risk after full adjustment for covariates. For Hispanic individuals, there was higher EOCRC mortality (AHR, 1.15 [95% CI, 1.08-1.22]) with the base model (adjustment for age, sex, and tumor characteristics), but the association disappeared once neighborhood socioeconomic status was added to the base model (AHR, 1.00 [95% CI, 0.94-1.06]). Similarly, there was higher EOCRC mortality among Southeast Asian individuals with the base model (AHR, 1.17 [95% CI, 1.03-1.34], but that association disappeared with the addition of insurance status to the model (AHR, 1.10 [95% CI, 0.96-1.25]). CONCLUSIONS AND RELEVANCE: In this cohort study, racial and ethnic disparities in EOCRC mortality were evident, with the highest burden among Native Hawaiian or Other Pacific Islander and non-Hispanic Black individuals. These results provide evidence of the role of social determinants of health in explaining these differences.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Prevalence of Overweight, Obesity, and Abdominal Obesity and Their Associated Factors in Duhok City, Kurdistan Region, Iraq: A Population-Based Cross-Sectional Study. Journal of obesity 66.0 2 Childhood, adolescent, and early adult exposures and cancer risk in middle to late adulthood. Carcinogenesis 56.0 3 Exposure to per-and polyfluoroalkyl substances and early-onset cancers. Carcinogenesis 37.0 4 TPMT and NUDT15 Pharmacogenomic Profiles in Peruvian Patients With Pediatric Hematologic Malignancies. Frontiers in bioscience (Scholar edition) 66.3 5 H3F3B gene mutation in chondroblastomas: a multicenter study. Acta orthopaedica et traumatologica turcica 57.5 6 Chondroblastoma: the relationship between local invasiveness, recurrence, and histopathological features. Acta orthopaedica et traumatologica turcica 58.5 7 Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015). Nature communications 86.12 8 Radiotherapy Reconstitutes the Collapsed miRNome of Progressive Neuroblastoma and Promotes a Favorable Tumor Evolutionary Shift. Frontiers in bioscience (Landmark edition) 65.64 9 [Surgical highlights of 2026 Rhinology Annual Conference: endoscopic resection of a juvenile nasopharyngeal angiofibroma with subdural intracranial extension]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 28.5 10 A multicenter international case series highlighting the management of pediatric nephrogenic adenoma. Journal of pediatric urology 58.9 11 The BCG Vaccine: Pharmacological Biotechnology and Expanding Immunological Horizons. Frontiers in bioscience (Elite edition) 70.5 12 Synergistic antitumor effect of HMGB2 targeting combined with MDM2 inhibitor in diffuse intrinsic pontine glioma therapy. Frontiers in oncology 59.9 13 Pediatric ectodermal dysplasia with immunodeficiency caused by a hemizygous IKBKG frameshift variant: a case report and literature review. Frontiers in immunology 73.1 14 Allogeneic hematopoietic stem cell transplantation is associated with improved survival compared with chemotherapy in patients with acute myeloid leukemia harboring favorable-risk genetic features at initial diagnosis: a single-center retrospective study. Frontiers in immunology 79.76 15 Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database. Frontiers in immunology 63.8 16 Development of a multidimensional disease burden assessment system for childhood neuroblastoma based on the social determinants of health theory. Frontiers in oncology 57.2 17 Case Report: Reconciling genomic ambiguity with clinical certainty in refractory panniculitis. Frontiers in immunology 50.72 18 Vitamin D signaling in thymic development and longevity. Frontiers in nutrition 42.1 19 Endobronchial fibroepithelial polyp presenting as persistent wheezing in a 9-year-old girl: a case report. Frontiers in pediatrics 50.3 20 Treatment patterns, intensive treatment, and hospitalization-related burden of juvenile generalized myasthenia gravis in Japan: a retrospective cohort study using a hospital-based claims database. Frontiers in neurology 77.64 21 Two-decade clinicopathological spectrum of gliomas at a tertiary center in LMIC: histological profile and the molecular diagnostic gap. Frontiers in oncology 64.9 22 Giant Mesenteric Cyst: A Case Series. International medical case reports journal 56.9 23 Application of Dual-Energy X-Ray Absorptiometry for Bone Mineral Density Screening in Pediatric, Adolescent, and Young Adult Cancer Survivors: A Multi-Institutional Study of 6 California Children's Hospitals. Journal of pediatric hematology/oncology 61.5 24 Childhood cancer and future cardiometabolic health. npj metabolic health and disease 56.9 25 Baseline Environmental Contamination Data and Model-based Screening of Children's Exposure-Risk Estimates from Metal(loid)-laden Vegetables and Soils. Toxicological sciences : an official journal of the Society of Toxicology 61.5 26 Beyond standard care: Fathers' perspectives on healthcare and related support services when caring for a child with a progressive life-limiting condition-A qualitative study. Palliative medicine 56.0 27 Bortezomib-based chemotherapy in Chinese pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A single-center retrospective study. Pediatric investigation 79.78 28 Succinate dehydrogenase (SDHB, SDHC, SDHD) gene variants significantly modify clinical outcomes in paraganglioma-pheochromocytoma but have a limited impact on head and neck paraganglioma. Genetics in medicine : official journal of the American College of Medical Genetics 63.0 29 Cervicothoracic dumbbell ganglioneuroblastoma with spinal canal involvement and bone marrow metastasis: a case report and systematic review. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 76.3 30 Pediatric osteoporosis: a comprehensive imaging-based review of diagnosis, differential diagnosis, and etiology. Skeletal radiology 58.4 31 Frameless VarioGuide biopsy for pediatric brainstem lesions in the molecular era: diagnostic performance and workflow characteristics in a comparative single-center series. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 59.9 32 Isolated clival Langerhans cell histiocytosis in a pediatric patient: systematic review and illustrative case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 75.8
PATIENT-FRIENDLY SUMMARY

Racial and Ethnic Variation in Survival in Early-Onset Colorectal Cancer.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic